Approval · Notice of Compliance 4209 · 1996
MONOCLATE-P: Notice of Compliance 4209
Issued March 26, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4209
- Date
- March 26, 1996
- Company
- Centeon L.L.C.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Blood coagulation product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MONOCLATE-P | 02215144 | Cancelled Post Market |
| MONOCLATE-P | 02215152 | Cancelled Post Market |
| MONOCLATE-P | 02215160 | Cancelled Post Market |
Medicinal ingredients
- ANTIHEMOPHILIC FACTOR (HUMAN) 350 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (HUMAN) 700 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (HUMAN) 1,500 UNIT per VIAL